COMPARISON OF FIRST LINE ORAL THERAPIES IN RELAPSING-REMITTING MULTIPLE SCLEROSIS: EFFICACY AND SAFETY OF DIMETHYL FUMARATE VS TERIFLUNOMIDE IN THE CHIETI EXPERIENCE